Abstract
Stem cell banking has been a topic of discussion and debate for more than a decade since the first public services to supply human embryonic stem cells (hESCs) were established in the USA and the UK. This topic has received a recent revival with numerous ambitious programmes announced to deliver large collections of human induced pluripotency cell (hiPSC) lines. This chapter will provide a brief overview charting the development of stem cell banks, their value, and their likely role in the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rottem S, Naot Y (1998) Subversion and exploitation of host cells by mycoplasma. Trends Microbiol 6:436–440
MacLeod RAF, Dirks WG, Matsuo Y et al (1998) Widespread intraspecies cross-contamination of human tumour cell lines arising at source. Int J Cancer 83:555–563
Andrews PW, Baker D, Benvinisty N et al (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 10(2 Suppl):1–44
Andrews PW, Arias-Diaz J, Auerbach J et al (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5(4):301–314
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Nakagawa M, Koyanagi M, Tanabe K et al (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26(1):101–106
Stacey G, Crook JM, Hei D, Ludwig T (2013) Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? Cell Stem Cell 13(4):385–388
Inamdar MS, Healy L, Sinha A, Stacey G (2012) Global solutions to the challenges of setting up and managing a stem cell laboratory. Stem Cell Rev 8(3):830–843
Stacey G (2012) Banking stem cells for research and clinical applications. Prog Brain Res 200:41–58
Stacey G, Masters JR (2008) Cryopreservation and banking of mammalian cell lines. Nat Protoc 3(12):1981–1989
Buta C, David R, Dressel R et al (2013) Reconsidering pluripotency tests: do we still need teratoma assays? Stem Cell Res 11:552–562
Müller FJ, Goldmann J, Löser P, Loring JF (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6(5):412–414
Müller FJ, Schuldt BM, Williams R et al (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8(4):315–317
Isasi R, Knoppers BM, Andrews PW et al (2012) Disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med 7(3):440–448
Gymrek M, McGuire AL, Golan D et al (2013) Identifying personal genomes by surname inference. Science 339(6117):321–324
Isasi R (2014) Stem cell research and banking: towards policy on disclosing research results and incidental findings. In: Dusko I (ed) Stem cell banking. Springer, New York, pp 29–40
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Stacey, G. (2017). Stem Cell Banking: A Global View. In: Crook, J., Ludwig, T. (eds) Stem Cell Banking. Methods in Molecular Biology, vol 1590. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6921-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6921-0_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6919-7
Online ISBN: 978-1-4939-6921-0
eBook Packages: Springer Protocols